MSMSD Partners, L.P.

Institutional investor · Portfolio as of Q1 2026

Top Holdings8 positions

Checking export access…
Activity:

LINDBLAD EXPEDITIONS HOLDINGS

1.6M$28.3M34.4%$17.300.00%
1 qtr
New
92

ODDITY TECH LTD

1.8M$23.8M29.0%$28.35-52.80%
11 qtrssince 2023-Q3
Unchanged
0

XPONENTIAL FITNESS INC

1.7M$10M12.1%$14.45-58.35%
16 qtrssince 2022-Q2
Unchanged
0

RENEW ENERGY GLOBAL PLC

2.1M$9.6M11.6%$7.78-41.13%
18 qtrssince 2021-Q4
Unchanged
0
EEXEEXDelisted

EMERALD HOLDING INC

1.4M$6.3M7.7%——
6 qtrssince 2024-Q4
Unchanged
0
SAFESAFE
REIT

Safehold Inc

222,644$3M3.7%$24.45-46.06%
13 qtrssince 2023-Q1
Unchanged
0

SERVICETITAN INC

18,388$1.2M1.4%$102.87-38.31%
6 qtrssince 2024-Q4
Unchanged
0

TRISALUS LIFE SCIENCES INC

39,999$159,9960.2%$4.61-13.23%
7 qtrssince 2024-Q3
Unchanged
0
$82.3M
AUM
8
Positions
Q1 2026
Filing
HI score · 1.5/5
Quarterly 13F Value Change
-10%Q4'24$142.3M-5%Q1'25$134.5M+28%Q2'25$172.1M-12%Q3'25$150.9M-28%Q4'25$108.6M-24%Q1'26$82.3M
Activity profile
$ moved · Q1'26
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.2 years
<1Q13%1-4Q0%1-2Y38%2Y+50%

MSD Partners, L.P. manages $82.3M across 8 positions as of Q1 2026. Top holdings: LIND (34.4%), ODD (29.0%), XPOF (12.1%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1.5/5.0.

Q1 2026 Summary

Added 1 new position. Top move: LIND (NEW, conviction 92). Portfolio: $82M across 8 positions.

Top holdings by portfolio weight

Total AUM$82M
LIND34.36%
ODD28.96%
XPOF12.10%
RNW11.64%
EEX7.67%
SAFE3.66%
TTAN1.42%
TLSI0.19%

Portfolio allocation by GICS sector

Sectors7
Consumer Cyclical46.47%
Consumer Defensive28.96%
Utilities11.64%
Communication Services7.67%
Real Estate3.66%
Technology1.42%
Healthcare0.19%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Consumer Cyclical, Consumer Defensive, Utilities
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L17
Conviction37
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used